3-iodobenzylguanidine has been researched along with Emesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleeker, G; Caron, HN; de Kraker, J; Hoefnagel, CA; Schoot, RA; Tytgat, GA; van Eck, BL | 1 |
Listernick, R | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Emesis
Article | Year |
---|---|
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis.
Topics: 3-Iodobenzylguanidine; Anemia; Child; Child, Preschool; Female; Humans; Infant; Male; Nausea; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Vomiting | 2013 |
1 other study(ies) available for 3-iodobenzylguanidine and Emesis
Article | Year |
---|---|
An 11-year-old boy with emesis, decreased appetite, fever.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Appetite; Blood Pressure; Cardiomyopathy, Hypertrophic; Child; Diagnosis, Differential; Fever; Humans; Male; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Radiopharmaceuticals; Vomiting | 2010 |